Funding for this research was provided by:
European and Developing Countries Clinical Trials Partnership (TMA2016SF-1511)
Received: 2 April 2020
Accepted: 17 February 2021
First Online: 1 April 2021
Ethics approval and consent to participate
: The rotavirus vaccine study (ROVAS II) was approved by the University of Zambia Biomedical Research Ethics Committee (UNZABREC), the National Health Research Authority (NHRA), and the Zambia Medicines Regulatory Authority (ZAMRA). Written informed consent was obtained from the parents of the participants, and a copy of the written consent is available on request for review by the Editor-in-Chief of this journal.
: Written informed consent was obtained from the respective patient’s legal guardians for publication of this case series report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal
: Consent for publication was sought from the National Health Research Authority of Zambia.
: The authors declare that they have no competing interests.